Table 3.
Prevalence of malaria at 36 weeks of gestation.
| Variable | Malaria parasites at 36 weeks, n (%) | X 2 | P-value | |
|---|---|---|---|---|
| Negative, 849 (74.1%) | Positive, 297 (25.9%) | |||
| Reported usage of SP | 14.73 | <0.0001 | ||
| Did not take SP | 149 (64.2) | 83 (35.8) | ||
| Took SP | 700 (76.6) | 214 (23.4) | ||
|
| ||||
| SP dosage | 37.86 | <0.0001 | ||
| No SP | 149 (64.2) | 83 (35.8) | ||
| <3 dose | 296 (69.2) | 132 (30.8) | ||
| ≥3 dose | 404 (83.1) | 82 (16.9) | ||
|
| ||||
| Reported ITN/SP usage | 26.75 | <0.001 | ||
| No ITN/SP use | 90 (61.2) | 57 (38.8) | ||
| Only SP use | 355 (72.3) | 136 (27.7) | ||
| Only ITN use | 59 (69.4) | 26 (30.6) | ||
| Both SP and ITN use | 345 (81.6) | 78 (18.4) | ||
Data are presented as count (percent). Categorical variables are compared using the Chi-square test, and P < 0.05 are considered statistically significant.